Clinical Trial: Evaluating an Ebola and a Marburg Vaccine in Uganda

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase IB Study to Evaluate the Safety and Immunogenicity of an Ebola DNA Plasmid Vaccine, VRC-EBODNA023-00-VP, and a Marburg DNA Plasmid Vaccine, VRC-MARDNA025-00-VP, in Healthy Adults in Kampala, U

Brief Summary: This study will test two new vaccines, one for Ebola and one for Marburg virus, to see if they are safe, if they have side effects, and if they create an immune response in people who receive them.